The Evolving Treatment Landscape of Head and Neck Cancer: BI Replay

On Demand

Duration: 59 Minutes

Original Date: January 25, 2026

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join us in conversation about head and neck cancer with Professor Kevin Harrington, consultant clinical oncologist at the Royal Marsden Hospital and a Professor in Biological Cancer Therapies at the Institute of Cancer Research specializing in research on targeted therapy for patients with head and neck cancers. This webinar will examine the current treatment landscape for head and neck squamous cell carcinoma (HNSCC), assess emerging therapeutic approaches, and discuss how innovation and changing epidemiology could shape outcomes for patients in the future.

The Evolving Treatment Landscape of Head and Neck Cancer: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.